磁共振成像在头颈部肿瘤放疗个体化中的新兴潜力:肿瘤学家的视角
头颈部肿瘤因解剖复杂且邻近危及器官,放疗仍伴明显并发症,需高质量影像和基于治疗中反应的个体化放疗。MRI软组织对比优于CT且无额外辐射,扩散加权、动态对比增强和内在磁敏感加权等功能序列可定量组织细胞密度、血管通透性/灌注和缺氧,有望在放疗前或放疗中依据其变化指导治疗调整。本文先概述解剖MRI序列在头颈部放疗中的应用,再讨论功能MRI序列用于个体化治疗的潜力与局限。
要点
- MRI软组织对比优于CT,可更好地勾画头颈部肿瘤和危及器官,且无额外辐射。
- 扩散加权、动态对比增强和内在磁敏感加权MRI可定量组织细胞密度、血管通透性/灌注和缺氧。
- 这些功能参数具有放射生物学相关性,可能依据放疗前或放疗中的变化指导治疗调整。
核心结论
- MRI在头颈部放疗计划中应用日益增多,功能MRI参数具有放射生物学相关性,可能依据放疗前或放疗中的变化指导治疗调整。
研究设计与样本
- 本文为肿瘤学家视角的综述,先概述解剖MRI序列在头颈部放疗中的应用,再讨论功能MRI序列用于个体化治疗的潜力与局限。
局限性
- 原文指出功能MRI序列在个体化治疗中存在局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Head and neck cancer (HNC) is a challenging tumour site for radiotherapy delivery owing to its complex anatomy and proximity to organs at risk (OARs) such as the spinal cord and optic apparatus. Despite significant advances in radiotherapy planning techniques, radiation-induced morbidities remain substantial. Further improvement would require high-quality imaging and tailored radiotherapy based on intratreatment response. For these reasons, the use of MRI in radiotherapy planning for HNC is rapidly gaining popularity. MRI provides superior soft-tissue contrast in comparison with CT, allowing better definition of the tumour and OARs. The lack of additional radiation exposure is another attractive feature for intratreatment monitoring. In addition, advanced MRI techniques such as diffusion-weighted, dynamic contrast-enhanced and intrinsic susceptibility-weighted MRI techniques are capable of characterizing tumour biology further by providing quantitative functional parameters such as tissue cellularity, vascular permeability/perfusion and hypoxia. These functional parameters are known to have radiobiological relevance, which potentially could guide treatment adaptation based on their changes prior to or during radiotherapy. In this article, we first present an overview of the applications of anatomical MRI sequences in head and neck radiotherapy, followed by the potentials and limitations of functional MRI sequences in personalizing therapy.
引用
- Wong KH, Panek R, Bhide SA, et al. The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective. Br J Radiol. 2017. PMID: 28256151. doi:10.1259/bjr.20160768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。